SAN DIEGO, Oct. 09, 2023 (GLOBE NEWSWIRE) — The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of ImmunityBio, Inc. IBRX. Investors, who purchased ImmunityBio, Inc. IBRX shares prior to May 2022 and continue to hold any of those NASDAQ: IBRX shares, have also…Read More
Lawsuit Notice Investors who lost money with ImmunityBio Inc NASDAQ IBRX shares should contact the Shareholders Foundation ImmunityBio NASDAQIBRX
